A

AprilBio Co Ltd
KOSDAQ:397030

Watchlist Manager
AprilBio Co Ltd
KOSDAQ:397030
Watchlist
Price: 47 500 KRW 1.5% Market Closed
Market Cap: 1.1T KRW

Wall Street
Price Targets

Price Targets Summary
AprilBio Co Ltd

Wall Street analysts forecast AprilBio Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AprilBio Co Ltd is 47 430 KRW with a low forecast of 33 330 KRW and a high forecast of 63 000 KRW.

Lowest
Price Target
33 330 KRW
30% Downside
Average
Price Target
47 430 KRW
0% Downside
Highest
Price Target
63 000 KRW
33% Upside
AprilBio Co Ltd Competitors:
Price Targets
BBIO
BridgeBio Pharma Inc
12% Upside
CGON
CG Oncology Inc
82% Upside
GNS
Genus PLC
15% Upside
GLTO
Galecto Inc
26% Upside
AGIO
Agios Pharmaceuticals Inc
13% Upside
TECX
AVROBIO Inc
282% Upside
IMMU
Mendus AB (publ)
227% Upside
RLYB
Rallybio Corp
35% Upside

Revenue
Forecast

Revenue Estimate
AprilBio Co Ltd

The compound annual growth rate of AprilBio Co Ltd's revenue for the next 3 years is 2%.

N/A
Past Growth
2%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
AprilBio Co Ltd

The compound annual growth rate of AprilBio Co Ltd's operating income for the next 3 years is -1%.

N/A
Past Growth
-1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
AprilBio Co Ltd

The compound annual growth rate of AprilBio Co Ltd's net income for the next 3 years is 1%.

N/A
Past Growth
1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AprilBio Co Ltd's stock price target?
Price Target
47 430 KRW

According to Wall Street analysts, the average 1-year price target for AprilBio Co Ltd is 47 430 KRW with a low forecast of 33 330 KRW and a high forecast of 63 000 KRW.

What is AprilBio Co Ltd's Revenue forecast?
Projected CAGR
2%

The compound annual growth rate of AprilBio Co Ltd's revenue for the next 3 years is 2%.

What is AprilBio Co Ltd's Operating Income forecast?
Projected CAGR
-1%

The compound annual growth rate of AprilBio Co Ltd's operating income for the next 3 years is -1%.

What is AprilBio Co Ltd's Net Income forecast?
Projected CAGR
1%

The compound annual growth rate of AprilBio Co Ltd's net income for the next 3 years is 1%.

Back to Top